Systemic absorption with complications during topical tacrolimus treatment for orofacial Crohn disease

Journal of Pediatric Gastroenterology and Nutrition

Volumn 32, Issue 2, 2001, Pages 207-208

  Russell, Richard K ^a   Richardson, Neil ^a   Wilson, David C ^b  

^a ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BUDESONIDE; FLUOXETINE; IRON; RANITIDINE; TACROLIMUS;

ADOLESCENT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CROHN DISEASE; DISEASE ASSOCIATION; DRUG ABSORPTION; DRUG MONITORING; DRUG SAFETY; FEMALE; HERPES ZOSTER; HUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME;

ABSORPTION; ADMINISTRATION, TOPICAL; ADOLESCENT; CROHN DISEASE; FEMALE; HERPES ZOSTER; HUMANS; IMMUNOSUPPRESSIVE AGENTS; TACROLIMUS;

HERPES; HERPES ZOSTER;

EID: 0035068889     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-200102000-00022     Document Type: Article

References (4)

1. A randomised, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children
2. Topical Tacrolimus may be effective in the treatment of oral and perineal Crohn's disease
3. Tacrolimus: The drug for the turn of the millennium?
4. Tacrolimus concentrations in blood during topical treatment of atopic dermatitis